135 related articles for article (PubMed ID: 36037931)
1. Simultaneous determination of emtricitabine, tenofovir alafenamide fumarate and dolutegravir sodium by validated stability-indicating RP-HPLC-DAD method.
Rathod SM; Patel NC; Patel PU
Ann Pharm Fr; 2023 Jan; 81(1):94-106. PubMed ID: 36037931
[TBL] [Abstract][Full Text] [Related]
2. A simple stability indicating RP-HPLC-DAD method for concurrent analysis of Tenofovir Disoproxil Fumarate, Doravirine and Lamivudine in pure blend and their combined film coated tablets.
Godela R; Gummadi S
Ann Pharm Fr; 2021 Nov; 79(6):640-651. PubMed ID: 34019910
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate.
Attaluri T; Seru G; Varanasi SNM
Turk J Pharm Sci; 2021 Sep; 18(4):410-419. PubMed ID: 34496481
[TBL] [Abstract][Full Text] [Related]
4. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
[TBL] [Abstract][Full Text] [Related]
5. Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms.
Venkatesan S; Kannappan N; Mannemala SS
Int Sch Res Notices; 2014; 2014():849149. PubMed ID: 27437485
[TBL] [Abstract][Full Text] [Related]
6. A Validated Stability Indicating RP-HPLC Method for the Determination of Emtricitabine, Tenofovir Disoproxil Fumarate, Elvitegravir and Cobicistat in Pharmaceutical Dosage Form.
Runja C; Kumar PR; Avanapu SR
J Chromatogr Sci; 2016; 54(5):759-64. PubMed ID: 26865655
[TBL] [Abstract][Full Text] [Related]
7. Development And Validation Of Rp-Hplc Method For The Estimation Of Tenofovir And Emtricitabine In Bulk And Pharmaceutical Dosage Form.
Sahoo BM; Rao PV; Rao NS
Curr Drug Res Rev; 2023 Jun; ():. PubMed ID: 37278041
[TBL] [Abstract][Full Text] [Related]
8. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
9. The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations.
Omoteso OA; Milne M; Aucamp M
Int J Anal Chem; 2022; 2022():3510277. PubMed ID: 35154325
[TBL] [Abstract][Full Text] [Related]
10. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial.
Venter WDF; Sokhela S; Simmons B; Moorhouse M; Fairlie L; Mashabane N; Serenata C; Akpomiemie G; Masenya M; Qavi A; Chandiwana N; McCann K; Norris S; Chersich M; Maartens G; Lalla-Edward S; Vos A; Clayden P; Abrams E; Arulappan N; Hill A
Lancet HIV; 2020 Oct; 7(10):e666-e676. PubMed ID: 33010240
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a stability-indicating RP-HPLC method for the identification, determination of related substances and assay of dimethyl fumarate in drug substance.
Kommareddy S; Nigam RS; Kumar S
Ann Pharm Fr; 2021 Mar; 79(2):179-193. PubMed ID: 33091397
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of stability indicating RP-HPLC method for simultaneous estimation of silodosin and mirabegron in synthetic mixture.
Mishra S; Surekha N; Chauhan A
Ann Pharm Fr; 2024 Mar; 82(2):243-262. PubMed ID: 38163458
[TBL] [Abstract][Full Text] [Related]
13. Validated stability indicating chromatographic method for determination of baricitinib and its degradation products in their tablet dosage form: Implementation to content uniformity and in vitro dissolution studies.
Mohamed MA
Ann Pharm Fr; 2023 Mar; 81(2):267-283. PubMed ID: 36126752
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
15. Stability Indicating RP-HPLC-DAD method for simultaneous estimation of tadalafil and macitentan in synthetic mixture for treatment of pulmonary arterial hypertension.
Gol D; Vyas A; Visana N; Patel A; Shah S; Sheth D; Dholakia S
Ann Pharm Fr; 2024 May; 82(3):464-472. PubMed ID: 37866638
[TBL] [Abstract][Full Text] [Related]
16. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir-An Eco-Friendly Approach.
Chandana M S; K S; A A; Narendra P; K S
J AOAC Int; 2024 May; 107(3):377-386. PubMed ID: 38318977
[TBL] [Abstract][Full Text] [Related]
17. Greens appraisal of validated stability indicating RP-HPLC method and forced degradation study for quantification of Ebastine in wastewater and dosage form.
Almalki MA; Alanazi TYA; Mahgoub SM; Abo El-Ela FI; Mohamed MA
Ann Pharm Fr; 2024 May; 82(3):420-432. PubMed ID: 37739216
[TBL] [Abstract][Full Text] [Related]
18. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir.
Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
Ann Pharm Fr; 2017 May; 75(3):176-184. PubMed ID: 28187879
[TBL] [Abstract][Full Text] [Related]
19. Method Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Dronedarone Hydrochloride in Pharmaceutical Tablets.
Dabhi B; Jadeja Y; Patel M; Jebaliya H; Karia D; Shah A
Sci Pharm; 2013; 81(1):115-22. PubMed ID: 23641332
[TBL] [Abstract][Full Text] [Related]
20. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
Stellbrink HJ; Arribas JR; Stephens JL; Albrecht H; Sax PE; Maggiolo F; Creticos C; Martorell CT; Wei X; Acosta R; Collins SE; Brainard D; Martin H
Lancet HIV; 2019 Jun; 6(6):e364-e372. PubMed ID: 31068272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
